MAP2K7 and melanoma: To develop an overall metric of adaptive response in RAF and MEK inhibitor-treated melanoma cells, we correlated target inhibition (as measured by pERK(Thr202/Tyr204) levels) 1 h after drug exposure with viability at 72 h across different cell lines representing diverse adaptive response signatures.